Venture Certified
| 혁신성장유형 | 2024-12-26 ~ 2027-12-25 | 20241226030054 | 2024-12-26 |
Revenue CAGR +6.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 167B | 148B | 147B |
| Operating Profit | 8.5B | 1.9B | 4.0B |
| Net Profit | 6.5B | 2.7B | 3.7B |
| Total Assets | 68B | 54B | 52B |
| Total Liabilities | 53B | 46B | 45B |
| Total Equity | 15B | 8.8B | 6.3B |
▲ 13.6%
▲ 187.7%
▲ 153.0%
▼ 41.1%
▼ 1.6%
| Name | Position | Role |
|---|---|---|
| 이주형 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| Clec9A-기반 키메라 단백질 제형 | 오리오니스 바이오사이언시즈 인코포레이티드 | 1020267000446 | 2024-06-07 | 공개 |
| 디스플레이 및 열관리 시스템 | 쿠오리 오와이 | 1020257040325 | 2024-04-11 | 공개 |
| 호르몬 감수성 전립선암의 생화학적 재발이 있는 환자의 치료를 위한 안드로겐 수용체 길항제 | 바이엘 컨수머 케어 악티엔게젤샤프트|오리온 코포레이션 | 1020257033860 | 2024-03-15 | 공개 |
| 타시피미딘과 CYP2D6 억제제의 병용 치료 | 오리온 코포레이션 | 1020257013954 | 2023-09-27 | 공개 |
| 이소크로만-이미다졸 구조의 알파-2A 아드레노셉터 작용제의 신규한 염 형태 | 오리온 코포레이션 | 1020247029586 | 2023-02-03 | 공개 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 성동구",
"ceo_name": "이주형",
"certificate": [
{
"cert_number": "20241226030054",
"changes": "",
"disclosure_date": "2024-12-26",
"first_cert_date": "2024-12-26",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2024-12-26 ~ 2027-12-25"
}
],
"company_name": "(주)오리오",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 28130000,
"cost_of_sales": 9696101000,
"current_assets": 4692565000,
"current_liabilities": 4518349000,
"gross_profit": 5005513000,
"net_income": 373214000,
"net_income_bs": 361480000,
"non_current_assets": 457609000,
"non_current_liabilities": 0,
"non_operating_expenses": 576171000,
"non_operating_income": 548303000,
"operating_profit": 401082000,
"revenue": 14701614000,
"sga_expenses": 4604431000,
"total_assets": 5150174000,
"total_equity": 631825000,
"total_liabilities": 4518349000
},
"2023": {
"capital_stock": 28130000,
"cost_of_sales": 9551572000,
"current_assets": 5062961000,
"current_liabilities": 4266852000,
"gross_profit": 5229273000,
"net_income": 269019000,
"net_income_bs": 249676000,
"non_current_assets": 371918000,
"non_current_liabilities": 286526000,
"non_operating_expenses": 114942000,
"non_operating_income": 194106000,
"operating_profit": 189855000,
"revenue": 14780845000,
"sga_expenses": 5039418000,
"total_assets": 5434879000,
"total_equity": 881501000,
"total_liabilities": 4553378000
},
"2024": {
"capital_stock": 28130000,
"cost_of_sales": 10612138000,
"current_assets": 6437404000,
"current_liabilities": 4800767000,
"gross_profit": 6133063000,
"net_income": 645871000,
"net_income_bs": 610943000,
"non_current_assets": 343697000,
"non_current_liabilities": 514553000,
"non_operating_expenses": 275024000,
"non_operating_income": 70813000,
"operating_profit": 850082000,
"revenue": 16745201000,
"sga_expenses": 5282981000,
"total_assets": 6781101000,
"total_equity": 1465781000,
"total_liabilities": 5315320000
}
},
"industry": "포장용 플라스틱 성형용기 제조업",
"investment": [],
"main_products": "생활용품",
"phone": "02-425-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |